Merck & Co MRK · USD
Health Care · Pharmaceuticals · US listing · 🇺🇸 United States
S&P 500Dow Jones
148.76
+1.38%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Merck & Co
From its filings with the US Securities and Exchange Commission
Merck & Co is based in Rahway, New Jersey and is incorporated in New Jersey. Its shares trade on NYSE under the ticker MRK. It is a member of the S&P 500 and Dow Jones. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $65.01bn and net income of $18.25bn. At that date it held total assets of $136.87bn and shareholders' equity of $52.61bn.
Merck & Co., Inc. (Merck or the Company) is a global health care company that delivers innovative health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s operations are principally managed on a product basis and include two operating segments, Pharmaceutical and Animal Health, both of which are reportable segments.
The Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies, and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities.
Quoted from its 10-K, filed 24 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 15 Jun 1946
- Employees
- 75,000
- Website
- merck.com ↗
- Head office
- 126 EAST LINCOLN AVENUE, RAHWAY, NJ, 07065
- Incorporated in
- NJ
- Classification
- Pharmaceutical Preparations
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Robert DavisChairman of the Board, President, Chief Executive Officer, since 2014$23.2m
- Ms. Caroline LitchfieldChief Financial Officer, Executive Vice President$7.5m
- Ms. Betty LarsonChief Human Resources Officer, Executive Vice President$11.3m
- Mr. David WilliamsExecutive Vice President, Chief Information and Digital Officer
- Ms. Jennifer ZacharyExecutive Vice President, General Counsel$5.9m
- Mr. Sanat ChattopadhyayExecutive Vice President and President - Merck Manufacturing Division$6.2m
- Mr. Richard DelucaExecutive Vice President, President - Merck Animal Health$9.1m
- Ms. Cristal DowningExecutive Vice President, Chief Communications and Public Affairs Officer
- Dr. Dean LiExecutive Vice President, President - Merck Research Laboratories, since 2021$10.1m
- Mr. Dalton SmartSenior Vice President Finance – Global Controller
- Mr. Chirfi GuindoSenior Vice President, Chief Marketing Officer - Human Health$13.9m
- Mr. Johannes OosthuizenSenior Vice President and President Merck U.S. Human Health
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 73
- Environment
- 79
- Social
- 88
- Governance
- 52
- Direct emissions (scope 1)
- 718,400 t
- Energy emissions (scope 2)
- 356,900 t
- Value chain emissions (scope 3)
- 6,184,100 t
- Women in the workforce
- 51%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Merck & Co Inc, a leading pharmaceutical company, possesses the following strengths:
- Merck & Co Inc faces the following weaknesses:
- Merck & Co Inc can explore the following opportunities:
- Merck & Co Inc faces the following threats:
Weaknesses
- Merck & Co Inc faces the following weaknesses:
- Merck & Co Inc can explore the following opportunities:
- Merck & Co Inc faces the following threats:
Opportunities
- Merck & Co Inc can explore the following opportunities:
- Merck & Co Inc faces the following threats:
Threats
- Merck & Co Inc faces the following threats:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.